Despite the plethora of knowledge regarding the phosphorylation of AR and its coactivators (e.g., by MAPKs, CDKs) in prostate cancer [44,45,46], only limited evidence exists for non-genomic crosstalk of AR with kinases. Here, AR is linked to prostate carcinoma.